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Introduction
Classic studies over the last two decades
have made virus-induced activation of the
mammalian interferon-b (ifnb) gene a pro-
totype of eukaryotic gene regulation [1–6].
Indeed, the compact ,50 base-pair en-
hancer region upstream of the ifnb tran-
scription start site is amongst the best-
studied stretches of mammalian DNA, and
its function in regulation of ifnb expression
is considered a paradigm of stimulus-
activated mammalian gene regulation.
In a widely accepted model, RNA virus
infection of most cell types triggers the
activation of three classes of transcription
factor—interferon regulatory factors
(IRFs)-3/7, NF-kB, and ATF-2/c-Jun—
downstream of the RIG-I-like receptor
(RLR) family of viral RNA sensors [7–9].
These transcription factors bind well-
defined adjacent sites in the ifnb enhancer
to nucleate formation of an ‘‘enhanceo-
some’’. The nascent enhanceosome then
recruits chromatin-modifying enzymes
and general transcription factors to initiate
transcription of ifnb and launch the type I
IFN antiviral innate immune response
[1,2,10]. Implicit in the inherently coop-
erative nature of enhanceosome formation
is the supposition that IRFs-3/7, NF-kB,
and ATF-2/c-Jun are all perhaps equally
necessary for virus-driven ifnb expression.
Recent findings from our laboratories and
other groups, however, suggest an alter-
nate view of NF-kB function in antivirus
responses: that NF-kB is indeed required
for ifnb expression, but only before (and
very early after) infection. As the infection
unfolds, NF-kB is no longer necessary for
ifnb induction, and instead takes on a
more general role in the expression of non-
IFN innate immune and pro-inflammatory
genes; meanwhile, IRFs-3/7 inherit ifnb
expression to propel the type I IFN
antiviral system. In this article, we update
the enhanceosome paradigm by proposing
temporally distinct functions for NF-kBi n
the RLR-triggered innate immune re-
sponse.
Unexpected Results from NF-kB
Gene-Targeted Mice
Given that IRFs-3/7, NF-kB, and ATF-
2/c-Jun assemble on the ifnb enhancer, it
was expected that all three factors would be
critical for virus-triggered induction of ifnb.
In line with this expectation, studies using
mice deficient in IRF-3 and/or IRF-7 have
convincingly shown essential roles for these
IRFs inproduction ofIFN-b andothertype
I IFNs [11–13]. We were therefore sur-
prised to discover that cells from mice
genetically deficient in key NF-kB subunits
(such as RelA, c-Rel, or p50) were mostly
normal in their ability to activate ifnb
expression after virus infection [14]. In-
deed, cells lacking virtually all detectable
RLR-triggeredNF-kB activity continuedto
support robust virus-induced ifnb expres-
sion [14,15]. Thus, while NF-kB is activat-
ed by virus infection and does associate with
the ifnb enhancer, it does not appear to be
required for subsequent transcription of ifnb.
These findings raise two key questions: (1)
what is the function of the NF-kB site in the
ifnb promoter, and (2) what is the function
of NF-kB in virus-triggered innate immune
responses, if not to activate ifnb?
Function of NF-kB before
Infection: Maintenance of Basal
ifnb Activity
Recent work has begun to provide
answers to both these questions. Using
an in silico approach to analyze cells
deficient in RelA (the primary transacti-
vating component of virus-induced NF-
kB), we have found that NF-kB controls
expression of several IFN-dependent in-
nate immune pathways by, unexpectedly,
maintaining constitutive expression of ifnb in
uninfected cells [16].
It has long been known that constitutive
low-level expression of ifnb is necessary for
maintenance of an IFN-b autocrine signal
that keeps the uninfected cell in a primed
state of antiviral readiness [17,18]. Since
the type I IFN antiviral system is depen-
dent on feed-forward signal amplification,
even small differences in basal gene
expression translate into major down-
stream deficiencies. We have found that
in the absence of RelA, basal expression of
ifnb is reduced, and autocrine IFN-b
signaling is compromised. Consequently,
there is a delay in the induction of ifnb
after infection, and, later, severe defects in
the activation of the type I IFN response
[14,16,19]. This tardiness in type I IFN
feed-forward signaling has negative conse-
quences for host antiviral immunity: RelA-
deficient embryo fibroblasts are very
susceptible to interferon-sensitive RNA
viruses such as vesicular stomatitis virus
(Rhabdoviridae), Newcastle disease virus,
and Sendai virus (both Paramyxoviridae),
despite producing copious amounts of
IFN-b later during the course of infection
[16,19]. In these cells, diminished IFN-b
expression prior to infection (and early
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a head start, and even though IFN-b
production eventually catches up to (and
even exceeds) wild-type levels, the tempo-
ral advantage conferred to the actively
replicating RNA viruses during an acute
infection ultimately proves insurmount-
able [16,19]. These findings highlight the
importance of timely IFN-b production
(rather than the maximal amount pro-
duced) in innate immunity to an acute
RNA virus infection.
The precise mechanism that generates
constitutive NF-kB activity is currently not
known. We have found that NF-kB cycles
robustly through the nuclei of uninfected
primary cells in an IKK-b-dependent
manner, and IKK-b-deficient cells are
also defective in autocrine IFN-b-mediat-
ed basal interferon-stimulated gene ex-
pression [16]. Our preliminary findings
suggest that neither tumor necrosis factor-
a nor Toll-like receptors (TLRs) lie
upstream of IKK-b as a source of
constitutive NF-kB [16].
Function of NF-kB Early in
Infection: Role in ifnb Induction
In addition to controlling constitutive
ifnb expression, NF-kB is also the earliest-
arriving virus-activated enhanceosome com-
ponent, appearing on the ifnb enhancer
within 2 hours of virus infection (and
approximately 2 and 4 hours ahead of
ATF-2 and IRF-3, respectively) [20].
Recent elegant experiments from the
Thanos laboratory show that NF-kB,
despite being found in rate-limiting
amounts in the cell, manages to gain such
rapid accessto the ifnb enhancer via a novel
process of inter-chromosomal transfer from
putative NF-kB ‘‘receptor centers’’ [21]. In
their model, specialized genomic loci con-
taining readily accessible NF-kB binding
sites serve as temporary receptors for
incoming nuclear NF-kB, following which
NF-kB is shuttled to either of two ifnb loci
to initiate monoallelic ifnb expression.Later
in an infection, feed-forward production of
IRF-7 drives bi-allelic ifnb expression to
accelerate the type I IFN response [21].
Consistent with this model, we have also
found that NF-kB has a key role in early
virus-induced ifnb expression [19]. This
early requirement for NF-kB may stem
from how the co-activator CBP/p300 is
recruited to the ifnb locus: an ,30 amino-
acid region within the NF-kB RelA
subunit (termed the ‘‘synergism domain’’)
has been demonstrated to be essential for
the initial capture and stabilization of
CBP/p300 at the enhanceosome [22].
Although IRFs and c-Jun can indepen-
Figure 1. Temporally distinct roles for NF-kB in antivirus innate immune responses. (A)
In uninfected cells, NF-kB cycles robustly through the nucleus to maintain constitutive expression
of basal ifnb and sustain sutocrine IFN-b signaling. (B) Early in an infection, NF-kB cooperates with
ATF-2/c-Jun and IRF-3 to recruit the transcription co-activator CBP/p300 to the ifnb enhancer. (C)
Later in an infection, IRF-3/7 powers expression of ifnb, and NF-kB is rendered redundant in the
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ability to synergize with other enhanceo-
some components to anchor CBP/p300
and bridge the enhanceosome to the RNA
polymerase II transcriptional machinery
appears to be unique to the NF-kB RelA
subunit [22–24]. Once CBP/p300 is at the
ifnb enhancer (3–4 hours post infection
[20]), IRFs are already robustly activated
and capable of binding CBP/p300 to drive
ifnb transcription without further require-
ment for NF-kB. Indeed, IRF-3 can form
a stable complex with CBP/p300 in the
absence of other enhanceosome compo-
nents [25,26], and data suggest that IRF-
39s transcriptional activity can almost
entirely be accounted for by its ability to
capture CBP/p300 [27]. Collectively,
these findings allow us to propose a model
in which, early in infection, low levels of
individual enhanceosome components co-
operate to tether CBP/p300 to the ifnb
locus in a manner crucially dependent on
NF-kB RelA. Later in infection (when
activated IRF-3 dimers are found in larger
amounts) IRF-3 can perform this function
by itself, and the requirement for NF-kBi s
obviated. It is very likely that a similar
IRF-3-dependent mechanism also ac-
counts for ifnb expression in the complete
absence of NF-kB RelA [14,19].
Function of NF-kB Later in
Infection: Regulating Pro-
Inflammatory and Anti-
Necroptotic Gene Expression
Once IRFs have been activated, NF-kB
appears to be unnecessary for ifnb expres-
sion, and instead switches to regulating a
distinct set of genes that comprise roughly
25% of all RLR targets [16]. The NF-kB-
dependent subset of the RLR transcrip-
tome is especially enriched for genes
encoding (1) chemokines, chemokine sig-
naling, and adhesion molecules, (2) matrix
metalloproteinases and allied proteases
involved in remodeling the extracellular
matrix, and (3) proteins involved in
antigen processing and presentation, in-
cluding a large number of classical and
non-classical major histocompatibility
class I molecules. In addition, RelA is also
weakly activated by IFN-b itself [16,28],
and is required for induction of a small
subset (,5%) of interferon-stimulated
genes (most notably those encoding che-
mokines CxCl11 and Ccl3) [16]. Finally,
RelA-deficient cells treated with the virus
mimetic poly(I:C) are very susceptible to a
novel form of cell death termed necropto-
sis [29,30], indicating that RelA might also
transcriptionally control a cell survival
program to prolong pro-inflammatory
gene expression from the infected cell
[16,31]. Collectively, these findings show
that the NF-kB arm of the type I IFN
antiviral response is focused primarily on
generating pro-inflammatory and pro-sur-
vival signals, rather than on activating cell-
intrinsic antiviral effectors (or on feed-
forward amplification of IFN signaling
itself).
Conclusions
We propose here an updated view of
NF-kB’s overall function in the innate
antivirus response, in which NF-kB has a
crucial constitutive (and early) role in ifnb
expression followed by an equally impor-
tant and potentially more general later
role in regulating expression of genes
involved in recruitment and activation of
the adaptive immune response. Interest-
ingly, other groups have demonstrated
that c-Jun also participates in maintenance
of autocrine IFN-b, while IRF-3 and IRF-
7 may not [32,33]. Taken together, these
findings support the idea that NF-kB and
c-Jun sustain basal/early ifnb expression,
while IRF-3 and IRF-7 instead dominate
IFN-b production following virus infection
(Figure 1). Important areas for future
investigation include: (1) the source of
constitutive NF-kB activity; (2) the role of
other IRFs (for example, IRF-1) in consti-
tutive ifnb expression; and (3) evaluation of
cell type-specific roles for different NF-kB
subunits in anti-virus responses in vivo. For
example, the key type I IFN producing
plasmacytoid dendritic cells utilize TLRs,
rather than RLRs, to activate ifnb [34]. Is
the requirement for—and subunit compo-
sition of—NF-kB in these cells the same as
it is in cells that deploy a RLR-driven IFN
response? Despite over two decades of
investigation, the regulation of ifnb expres-
sion continues to throw up surprises, and
more unanticipated findings are likely
forthcoming.
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